Kiniksa Pharmaceuticals International, plc (KNSA) Net margin 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) net profit margin by fiscal year — reported net income divided by reported revenue.
8.7%FY2025 · since FY2021: -409.7% → 8.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.7% | +18.9 pp |
| FY2024 | -10.2% | -15.4 pp |
| FY2023 | 5.2% | -78.1 pp |
| FY2022 | 83.3% | +493.0 pp |
| FY2021 | -409.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KNSA financial trends
KNSA RevenueKNSA Net incomeKNSA Gross profitKNSA Gross marginKNSA Operating incomeKNSA Operating marginKNSA Operating cash flowKNSA Free cash flowKNSA Capital expendituresKNSA Return on equityKNSA Stock buybacksKNSA Dividends paidKNSA Total assetsKNSA Total liabilitiesKNSA Shareholders’ equityKNSA overview →